Cargando…
Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Leishmaniasis is a protozoan parasitic disease endemic to the tropical and subtropical regions of the world, with three major clinical forms, self-healing cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). Drug treatments are expensive and often result...
Autores principales: | Selvapandiyan, Angamuthu, Dey, Ranadhir, Gannavaram, Sreenivas, Lakhal-Naouar, Ines, Duncan, Robert, Salotra, Poonam, Nakhasi, Hira L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168768/ https://www.ncbi.nlm.nih.gov/pubmed/21912560 http://dx.doi.org/10.1155/2012/631460 |
Ejemplares similares
-
Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
por: Gannavaram, Sreenivas, et al.
Publicado: (2014) -
Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
por: Avishek, Kumar, et al.
Publicado: (2016) -
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
por: Bhattacharya, Parna, et al.
Publicado: (2016) -
Identification and Characterization of Genes Involved in Leishmania Pathogenesis: The Potential for Drug Target Selection
por: Duncan, Robert, et al.
Publicado: (2011) -
Innovations for the elimination and control of visceral leishmaniasis
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2019)